Search for Clinical Trial Results

Sponsored By

Alopecia - 200 Studies Found

Status Study
Completed Study Name: Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Condition: Alopecia
Date: 2010-04-26
Interventions: Drug: Clobetasol Propionate 0.05% Emollient Foam Clobetasol Propionate 0.05% E Foam to be applied to aff
Completed Study Name: Plaquenil for Alopecia Areata, Alopecia Totalis
Condition: Alopecia Areata
Date: 2005-09-12
Interventions: Drug: Hydroxychloroquine
Terminated Study Name: A Study of Secukinumab for the Treatment of Alopecia Areata
Condition: Alopecia Areata
Date: 2015-11-04
Interventions:
  • Drug: Secukinumab subcutaneous
Completed Study Name: Alefacept in Patients With Severe Scalp Alopecia Areata
Condition: Alopecia Areata
Date: 2005-09-09
Interventions: Drug: Alefacept Study participants will receive weekly IM administration of placebo or 15 mg of alefacep
Active, not recruiting Study Name: Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
Condition: Alopecia Areata
Date: 2014-11-14
Interventions: Drug: Tofacitinib Other Name: XELJANZ
Completed Study Name: Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
Condition: Alopecia Areata
Date: 2006-12-05
Interventions: Drug: Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units
Active, not recruiting Study Name: Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Date: 2016-02-11
Interventions:
  • Drug: Apremilast Subjects will
Withdrawn Study Name: Childhood Alopecia Areata Study Using the 308-nm Excimer Laser
Condition: Alopecia Areata
Date: 2012-11-01
Interventions:
  • Device: 308-nm excimer laser to alopecia patch

Withdrawn Study Name: The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia
Condition: Alopecia
Date: 2005-09-12
Interventions: Drug: roxithromycin
Recruiting Study Name: A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Date: 2016-02-11
Interventions:
  • Drug: Tralokinumab All groups

Next >>>